Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z7QZ
|
|||
| Former ID |
DNC007406
|
|||
| Drug Name |
N-(thiazol-2-yl)benzamide
|
|||
| Synonyms |
N-(1,3-Thiazol-2-yl)benzamide; N-Thiazol-2-yl-benzamide; SCQBDADQAVXTMZ-UHFFFAOYSA-N; 13053-82-2; N-(thiazol-2-yl)benzamide; Benzamide, N-2-thiazolyl-; AC1LC4SL; AC1Q5LQU; n-thiazol-2-yl benzamide; N-(2-Thiazolyl)benzamide; MLS000711892; SCHEMBL995829; CHEMBL90846; Benzamide, N-(2-thiazolyl)-; IFLab1_003538; ZINC39994; MolPort-000-557-753; HMS1422A18; HMS2643F11; N-(1,3-Thiazol-2-yl)benzamide #; STK018313; AKOS005145274; AKOS000638160; MCULE-9395155160; IDI1_009645; SMR000281659; phenyl-N-(1,3-thiazol-2-yl)carboxamide; BAS 00332640
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H8N2OS
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C(=O)NC2=NC=CS2
|
|||
| InChI |
1S/C10H8N2OS/c13-9(8-4-2-1-3-5-8)12-10-11-6-7-14-10/h1-7H,(H,11,12,13)
|
|||
| InChIKey |
SCQBDADQAVXTMZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 13053-82-2
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | LOX-5 messenger RNA (ALOX5 mRNA) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Arachidonic acid metabolism | |||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.